Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
- Resource Type
- Article
- Source
- In
Immuno-Oncology and Technology September 2022 15 - Subject
- Language
- ISSN
- 2590-0188